SCHEMBL17453058

SCHEMBL17453058

CN[SH]1(=O)C[C@@](C)(c2cc([N+](=O)[O-])ccc2F)N/C(=N\C(=O)OC(C)(C)C)N1C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
THRB P10828 2/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DRD2 P14416 1/20 0.32
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32
WDR5 P61964 2/20 0.31
MAPT P10636 4/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31
BACE2 Q9Y5Z0 2/20 0.31
BACE1 P56817 1/20 0.31
NR3C2 P08235 1/20 0.31
SLC6A9 P48067 1/20 0.30
SLC6A5 Q9Y345 1/20 0.30
HSPA9 P38646 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17453060 0.87 BACE1 (0.31) BACE1
SCHEMBL17451548 0.81 MAPT (0.34) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL17453061 0.80 MAPT (0.33) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL10328600 0.79 BACE2 (0.38) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL15895250 0.79 BACE2 (0.38) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL17451540 0.78 MAPT (0.33) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL15895222 0.76 BACE2 (0.36) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL10328608 0.76 BACE2 (0.36) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL10328606 0.76 BACE2 (0.36) ALDH1A1THRBGAAHTTL3MBTL1
SCHEMBL17453064 0.75 BACE2 (0.36) ALDH1A1THRBGAAHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9428476-B2 S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use MERCK SHARP & DOHME CORP. (US) 2016-08-30 US disclosed
US-20160016923-A1 S-IMINO-S-OXO-IMINOTHIADIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016923-A1 S-IMINO-S-OXO-IMINOTHIADIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE BACE1, BACE2, APP ALDH1A1 335/4885THRB 1459/4885GAA 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.